It has been reported that NHERF1 overexpression reduced activation of AKT and ERK signaling as well as proliferative, migratory, and invasive abilities of both breast cancer cells and lung cancer cells [11,12,13,14]. This evidence concerns the gene NHERF1 and breast cancer.